Genomic Solutions Settles Lawsuit with PerkinElmer: Q1 Revenues Increase | GenomeWeb

NEW YORK, April 19 –Genomic Solutions and PerkinElmer have settled a lawsuit over PerkinElmer’s stake in Genomic Solutions stock, the companies said Thursday. 

Genomic Solutions also released financial results for the first quarter of 2001 Thursday, reporting that revenues increased 10 percent over the year-ago quarter to $4.4 million, and that losses totaled 12 cents per share, 4 cents more than Wall Street had expected, according to a survey of one broker conducted by FirstCall/Thomson Financial.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.